These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22589510)

  • 1. Towards greater transparency in the life sciences.
    Thompson R; Khanna D
    BMJ; 2012 May; 344():e3371. PubMed ID: 22589510
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidance offers little in the way of ethics or transparency.
    Rogers W; Zutlevics T; Raven M; Jureidini J
    BMJ; 2012 Apr; 344():e2910. PubMed ID: 22531804
    [No Abstract]   [Full Text] [Related]  

  • 3. Falling out with pharma.
    Whitehead S
    Lancet; 2013 Mar; 381(9872):1096-7. PubMed ID: 23540851
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations on conflict of interest, including relationships with industry.
    FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health
    Int J Gynaecol Obstet; 2015 Mar; 128(3):282-3. PubMed ID: 25458415
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.
    Cosgrove L; Krimsky S; Wheeler EE; Peters SM; Brodt M; Shaughnessy AF
    Account Res; 2017; 24(2):99-115. PubMed ID: 27901595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
    Kirkland KB
    Clin Infect Dis; 2010 Jan; 50(1):93-7. PubMed ID: 19951230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doctors' groups are criticised for endorsing pro-industry guidelines.
    Arie S
    BMJ; 2013 Oct; 347():f6066. PubMed ID: 24107354
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolve the Conflict Rather than Dissolve the Relationship.
    Wong SL; Stain SC
    Ann Surg Oncol; 2019 Aug; 26(8):2325-2326. PubMed ID: 31161287
    [No Abstract]   [Full Text] [Related]  

  • 10. Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.
    Grundy Q; Tierney L; Mayes C; Lipworth W
    J Bioeth Inq; 2017 Dec; 14(4):541-553. PubMed ID: 28913595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dos and don'ts of collaborating with industry.
    Moynihan R
    BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
    [No Abstract]   [Full Text] [Related]  

  • 12. A positive step for pharmaceutical payment transparency.
    Dean J; Forbes MP; Di Natale R
    Med J Aust; 2017 May; 206(9):414. PubMed ID: 28490312
    [No Abstract]   [Full Text] [Related]  

  • 13. Letting the sunshine in on doctor-pharma relationships.
    Jack A
    BMJ; 2011 Oct; 343():d6459. PubMed ID: 21990283
    [No Abstract]   [Full Text] [Related]  

  • 14. When disclosures are more interesting than the evidence.
    Holloway RG; Benesch C
    Stroke; 2009 Feb; 40(2):e44; author reply e45. PubMed ID: 19095995
    [No Abstract]   [Full Text] [Related]  

  • 15. Disclosing payments from drug companies should be mandatory for doctors, says academy.
    Torjesen I
    BMJ; 2015 Aug; 351():h4197. PubMed ID: 26240077
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial publications.
    Bhatt AD
    Issues Med Ethics; 2000; 8(4):119-21. PubMed ID: 16323375
    [No Abstract]   [Full Text] [Related]  

  • 17. Disclosure UK: transparency should no longer be an optional extra.
    Adlington K; Godlee F
    BMJ; 2016 Jul; 354():i3730. PubMed ID: 27383187
    [No Abstract]   [Full Text] [Related]  

  • 18. Between two cultures: the expert clinician and the pharmaceutical industry.
    Gale EA
    Clin Med (Lond); 2003; 3(6):538-41. PubMed ID: 14703033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosure UK website gives "illusion of transparency," says Goldacre.
    Kmietowicz Z
    BMJ; 2016 Jul; 354():i3760. PubMed ID: 27384062
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):471-8. PubMed ID: 22464101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.